Bayer Bites Back At Teva's Xarelto Invalidation Suit
German pharmaceutical giant Bayer has asked a London court to prevent Teva from selling its planned generic blood-thinner in the U.K., firing back at the Israeli company's bid to nix one...To view the full article, register now.
Already a subscriber? Click here to view full article